Related Experiment Video
Updated: Jan 16, 2026

23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
17.1K
Paediatric, age-specific reference intervals for reticulocyte count on Abbotts Alinity hq platform
Rie H Nygaard1, Rie McGrail1, Cristine Betzer1
1Department of Clinical Biochemistry, Gødstrup Hospital, Herning, Denmark.
Scandinavian Journal of Clinical and Laboratory Investigation
|October 6, 2025
Summary
New paediatric reference intervals for reticulocyte count on Abbott platforms are now available. This study establishes crucial reference ranges for children, aiding accurate interpretation of blood analyses.
Area of Science:
- Clinical Chemistry
- Paediatric Haematology
Background:
- Accurate haematological analysis in children requires specific paediatric reference intervals.
- Paediatric reference intervals for reticulocyte count are lacking for Abbott platforms.
Purpose of the Study:
- To establish paediatric reference intervals for reticulocyte count using Abbott's Alinity hq platform.
- To provide essential data for interpreting reticulocyte counts in children up to 18 years old.
Main Methods:
- Utilized a data-mining approach on reticulocyte counts from Abbott's Alinity hq platform.
- Included samples from 'healthiest patients' with normal haemoglobin and single reticulocyte counts (n=1633).
- Data extracted from July 2021 to November 2024.
Main Results:
- Established reference intervals for the first week of life (0-<7 days): 74-442 *10^9/L.
- Established reference intervals for children aged 7 days to 18 years: 32-115 *10^9/L.
- Observed higher reticulocyte counts compared to other platforms, consistent with adult data on Abbott platforms.
Conclusions:
- This is the first study to report paediatric reticulocyte count reference intervals on an Abbott platform.
- The established intervals are higher than those reported on other platforms.
- These findings support clinical decision-making for laboratories using the Alinity hq platform.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Pharmacokinetics in Pediatric Patients: Drug Distribution
252
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
252

